UniProt ID | IF2B1_MOUSE | |
---|---|---|
UniProt AC | O88477 | |
Protein Name | Insulin-like growth factor 2 mRNA-binding protein 1 | |
Gene Name | Igf2bp1 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 577 | |
Subcellular Localization | Nucleus. Cytoplasm. Cytoplasm, perinuclear region. Cell projection, lamellipodium. Cell projection, dendrite. Cell projection, dendritic spine. Cell projection, growth cone. Cell projection, filopodium. Cell projection, axon. In the nucleus, located | |
Protein Description | RNA-binding factor that recruits target transcripts to cytoplasmic protein-RNA complexes (mRNPs). This transcript 'caging' into mRNPs allows mRNA transport and transient storage. It also modulates the rate and location at which target transcripts encounter the translational apparatus and shields them from endonuclease attacks or microRNA-mediated degradation. Regulates localized beta-actin/ACTB mRNA translation, a crucial process for cell polarity, cell migration and neurite outgrowth. Co-transcriptionally associates with the ACTB mRNA in the nucleus. This binding involves a conserved 54-nucleotide element in the ACTB mRNA 3'-UTR, known as the 'zipcode'. The RNP thus formed is exported to the cytoplasm, binds to a motor protein and is transported along the cytoskeleton to the cell periphery. During transport, prevents ACTB mRNA from being translated into protein. When the RNP complex reaches its destination near the plasma membrane, IGF2BP1 is phosphorylated. This releases the mRNA, allowing ribosomal 40S and 60S subunits to assemble and initiate ACTB protein synthesis. Monomeric ACTB then assembles into the subcortical actin cytoskeleton (By similarity). During neuronal development, key regulator of neurite outgrowth, growth cone guidance and neuronal cell migration, presumably through the spatiotemporal fine tuning of protein synthesis, such as that of ACTB (By similarity). May regulate mRNA transport to activated synapses (By similarity). Binds to the 3'-UTR of CD44 mRNA and stabilizes it, hence promotes cell adhesion and invadopodia formation in cancer cells (By similarity). Binds to the oncofetal H19 transcript and regulates its localization (By similarity). Binds to and stabilizes BTRC/FBW1A mRNA (By similarity). Binds to the adenine-rich autoregulatory sequence (ARS) located in PABPC1 mRNA and represses its translation. PABPC1 mRNA-binding is stimulated by PABPC1 protein. Prevents BTRC/FBW1A mRNA degradation by disrupting microRNA-dependent interaction with AGO2 (By similarity). During cellular stress, such as oxidative stress or heat shock, stabilizes target mRNAs that are recruited to stress granules, including CD44, IGF2, MAPK4, MYC, PTEN, RAPGEF2 and RPS6KA5 transcripts (By similarity). Interacts with GAP43 transcript and transports it to axons. Binds to the 3'-UTR of IGF2 mRNA by a mechanism of cooperative and sequential dimerization and regulates IGF2 mRNA subcellular localization and translation. Binds to MYC mRNA, in the coding region instability determinant (CRD) of the open reading frame (ORF), hence prevents MYC cleavage by endonucleases and possibly microRNA targeting to MYC-CRD. Binds to and stabilizes ABCB1/MDR-1 mRNA. Binds to the neuron-specific TAU mRNA and regulates its localization. Plays a direct role in the transport and translation of transcripts required for axonal regeneration in adult sensory neurons. During interstinal wound repair, interacts with and stabilizes PTGS2 transcript. PTGS2 mRNA stabilization may be crucial for colonic mucosal wound healing.. | |
Protein Sequence | MNKLYIGNLNESVTPADLEKVFAEHKISYSGQFLVKSGYAFVDCPDEHWAMKAIETFSGKVELQGKRLEIEHSVPKKQRSRKIQIRNIPPQLRWEVLDSLLAQYGTVENCEQVNTESETAVVNVTYSNREQTRQAIMKLNGHQLENHALKVSYIPDEQITQGPENGRRGGFGSRGQPRQGSPVAAGAPAKQQPVDIPLRLLVPTQYVGAIIGKEGATIRNITKQTQSKIDVHRKENAGAAEKAISVHSTPEGCSSACKMILEIMHKEAKDTKTADEVPLKILAHNNFVGRLIGKEGRNLKKVEQDTETKITISSLQDLTLYNPERTITVKGAIENCCRAEQEIMKKVREAYENDVAAMSLQSHLIPGLNLAAVGLFPASSSAVPPPPSSVTGAAPYSSFMQAPEQEMVQVFIPAQAVGAIIGKKGQHIKQLSRFASASIKIAPPETPDSKVRMVVITGPPEAQFKAQGRIYGKLKEENFFGPKEEVKLETHIRVPASAAGRVIGKGGKTVNELQNLTAAEVVVPRDQTPDENDQVIVKIIGHFYASQMAQRKIRDILAQVKQQHQKGQSNLAQARRK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
12 | Phosphorylation | YIGNLNESVTPADLE EECCCCCCCCHHHHH | 30.16 | 29514104 | |
20 | Ubiquitination | VTPADLEKVFAEHKI CCHHHHHHHHHHCCC | 50.37 | - | |
26 | Ubiquitination | EKVFAEHKISYSGQF HHHHHHCCCEECCEE | 25.50 | - | |
39 | Phosphorylation | QFLVKSGYAFVDCPD EEEEEECEEEEECCC | 12.17 | 22817900 | |
56 | Phosphorylation | WAMKAIETFSGKVEL HHHHHHHHCCCEEEE | 19.58 | 23984901 | |
58 | Phosphorylation | MKAIETFSGKVELQG HHHHHHCCCEEEECC | 45.16 | 23984901 | |
73 | Phosphorylation | KRLEIEHSVPKKQRS EEEEEEECCCCCCCC | 27.59 | - | |
181 | Phosphorylation | RGQPRQGSPVAAGAP CCCCCCCCCCCCCCC | 14.09 | 27087446 | |
190 | Ubiquitination | VAAGAPAKQQPVDIP CCCCCCCCCCCCCCC | 48.70 | - | |
213 | Ubiquitination | YVGAIIGKEGATIRN HHHHHHCCCCCCHHH | 42.43 | - | |
223 | Ubiquitination | ATIRNITKQTQSKID CCHHHHCHHHHCCEE | 47.77 | - | |
272 | Ubiquitination | HKEAKDTKTADEVPL HHHHCCCCCCCCCCC | 52.42 | - | |
313 | Phosphorylation | TETKITISSLQDLTL CCCCEEEEECCCCCC | 19.15 | 22006019 | |
314 | Phosphorylation | ETKITISSLQDLTLY CCCEEEEECCCCCCC | 26.63 | 22006019 | |
396 | Phosphorylation | SVTGAAPYSSFMQAP CCCCCCCCCHHCCCC | 16.54 | 21964071 | |
397 | Phosphorylation | VTGAAPYSSFMQAPE CCCCCCCCHHCCCCH | 18.95 | - | |
398 | Phosphorylation | TGAAPYSSFMQAPEQ CCCCCCCHHCCCCHH | 20.92 | - | |
436 | Phosphorylation | KQLSRFASASIKIAP HHHHHHHHCCEEECC | 21.60 | 25338131 | |
438 | Phosphorylation | LSRFASASIKIAPPE HHHHHHCCEEECCCC | 23.17 | 25338131 | |
440 | Ubiquitination | RFASASIKIAPPETP HHHHCCEEECCCCCC | 30.25 | - | |
446 | Phosphorylation | IKIAPPETPDSKVRM EEECCCCCCCCCEEE | 37.86 | 22006019 | |
450 | Ubiquitination | PPETPDSKVRMVVIT CCCCCCCCEEEEEEE | 41.04 | - | |
475 | Ubiquitination | GRIYGKLKEENFFGP CCEEEECCCCCCCCC | 67.48 | - | |
483 | Ubiquitination | EENFFGPKEEVKLET CCCCCCCHHHEEEEE | 67.87 | - | |
508 | Ubiquitination | RVIGKGGKTVNELQN CEECCCCCCHHHHHH | 58.95 | - | |
528 | Phosphorylation | VVVPRDQTPDENDQV EEECCCCCCCCCCCE | 36.68 | 25619855 | |
566 | Ubiquitination | QVKQQHQKGQSNLAQ HHHHHHHHHHCHHHH | 57.71 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of IF2B1_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of IF2B1_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of IF2B1_MOUSE !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large scale localization of protein phosphorylation by use ofelectron capture dissociation mass spectrometry."; Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.; Mol. Cell. Proteomics 8:904-912(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181, AND MASSSPECTROMETRY. |